Global Next-Generation Wearable Holter Device Market Growth 2025-2031

The global Next-Generation Wearable Holter Device market size is predicted to grow from US$ 1374 million in 2025 to US$ 1702 million in 2031; it is expected to grow at a CAGR of 3.6% from 2025 to 2031.

A Holter monitor is a small, wearable device that records your heart activity for typically 24 to 72 hours, and up to 7 to 14 days. The device is small, lightweight, and hangs around your neck while connecting cable to sensors attached to your chest. A Holter monitor captures all your heart activity throughout the day and while your sleep. This allows a physician to determine if there are intermittent abnormalities to your heart rhythm over an extended period of time. The test is safe and painless.

Abnormal heartbeats are called arrhythmias. It causes a decrease in the heart"s ability to pump blood, which reduces blood supply to vital organs such as the brain. Without proper blood flow to the brain, it can cause a person to faint, and when the rhythm returns to normal, the person regains consciousness. Therefore, heart rhythm is associated with many diseases and requires treatment. It is important to look for the cause of the rhythm disturbance and monitor electrical activity. This can be monitored with the help of an implantable heart monitor, which has a battery life of up to three or four years. The ICM continuously monitors heart rhythm and automatically stores records for years in real-world scenarios. With the capability of long-term continuous monitoring, ICM has proven to be a sensitive method for detecting unexplained syncope, subclinical atrial fibrillation and palpitations. These devices automatically record heart rate without any external intervention. The ICM can capture information that is often missed by a Holter or standard electrocardiogram (ECG), but some heart rhythm abnormalities occur rarely. Existing studies of these devices have provided sufficient evidence that implantable heart monitors are suitable for patients with atrial fibrillation, syncope and even myocardial infarction.

Atrial fibrillation is an irregular and often rapid heart rate that increases the risk of stroke, heart failure and other heart-related complications. It is expected to affect 17.9 million people by 2050. Short-term monitoring is not optimal for understanding the burden. After radiofrequency ablation, the ICM has become the first choice for cardiac monitoring. Fainting is a disorder triggered by a sudden, temporary drop in blood flow to the brain, resulting in loss of consciousness and muscle control. This is due to decreased blood flow to the brain or any other organ in the body. Low blood pressure can also cause passing out. The International Study of Syncope of Unknown Etiology (ISSUE) highlights various aspects of the utility of ICMs in the transient loss of consciousness (TLOC) population. It has been observed that ICM is used more in syncope than conventional testing. Myocardial infarction, commonly known as a heart attack, is said to occur when blood flow to the heart is blocked or completely stopped. The use of ICMs in patients with acute myocardial infarction allows for continuous ECG monitoring and a more detailed understanding of the incidence of bradyarrhythmias and tachyarrhythmias than conventional follow-up.

LP Information, Inc. (LPI) ' newest research report, the “Next-Generation Wearable Holter Device Industry Forecast” looks at past sales and reviews total world Next-Generation Wearable Holter Device sales in 2024, providing a comprehensive analysis by region and market sector of projected Next-Generation Wearable Holter Device sales for 2025 through 2031. With Next-Generation Wearable Holter Device sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Next-Generation Wearable Holter Device industry.

This Insight Report provides a comprehensive analysis of the global Next-Generation Wearable Holter Device landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Next-Generation Wearable Holter Device portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Next-Generation Wearable Holter Device market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Next-Generation Wearable Holter Device and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Next-Generation Wearable Holter Device.

This report presents a comprehensive overview, market shares, and growth opportunities of Next-Generation Wearable Holter Device market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

Chest Strap

ECG Patches

Segmentation by Application:

E-commerce

Offline

This report also splits the market by region:

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

Baxter

SmartCardia

AliveCor

iRhythm Technologies Inc

MediBioSense Ltd

Philips

LifeLabs

Aerotel Medical Systems

HeartBug

Wellue

Bardy Diagnostics

Coala Life

ScottCare

Biotricity

Cardiac Insight

Icentia Inc

Ranealth

Key Questions Addressed in this Report

What is the 10-year outlook for the global Next-Generation Wearable Holter Device market?

What factors are driving Next-Generation Wearable Holter Device market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Next-Generation Wearable Holter Device market opportunities vary by end market size?

How does Next-Generation Wearable Holter Device break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.